Peter Ghoroghchian is the founder of Latus Bio. Latus Bio has raised $97M in total funding. Latest round: Series A. Backed by 8VC, DCVC Bio, BioAdvance.
Peter Ghoroghchian is the Chief Executive Officer of Latus Bio, a gene therapy company. Latus Bio closed a $97 million Series A financing, which included a $43 million extension led by 8VC. The company focuses on developing therapeutics for neurological disorders, with lead programs for Huntington's disease and late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease.
Full founder directory · Investor directory · Company funding database · Fundraising library